vTv Therapeutics CEO Deepa Prasad receives $3.3M in 2021
vTv Therapeutics reports 2021 executive compensation
By ExecPay News
Published: May 2, 2022
vTv Therapeutics reported fiscal year 2021 executive compensation information on May 2, 2022.
In 2021, three executives at vTv Therapeutics received on average a compensation package of $2M, a 107% increase compared to previous year.
Deepa Prasad, Chief Executive Officer, received $3.3M in total. 96% of Prasad's compensation, or $3.2M, was in option awards. Prasad also received $133K in salary.
Stephen L. Holcombe, Chief Executive Officer, received a compensation package of $1.9M, which increased by 36% compared to previous year. 41% of the compensation package, or $780K, was in option awards.
Rudy C. Howard, Chief Financial Officer, earned $881K in 2021, a 6% decrease compared to previous year.